Quick links

Secure file transfer protocol Register or renew user

Contact us

Trouble logging in? Forgot password? We can help!

philavax@phila.gov

215-685-6784

215-238-6944

To onboard a new entity or clinic:

Complete the online reporting agreement form

Or fill out the

Reporting agreement form

then email it to
vaxreporting​@phila.gov
or fax to the contact above.

Clinic onboarding list

Complete in addition to the reporting agreement form to onboard more than 2 clinics.

Need help? Review the FAQ

Reporting agreement FAQ

On behalf of patients

Patient update request

Looking for something else?

PhilaVax program information

Flat file reporting guide

More PhilaVax resources

2025-2026 COVID-19 Vaccine Available Through VFC

08 Oct 2025 2025-2026 COVID-19 Vaccine Available Through VFC

Posted at 16:07h in Clinical Updates, COVID-19, General, VFC

VFC providers can now order Moderna, Pfizer, & Sanofi 2025-2026 COVID-19 products for their eligible patients.

Make sure that your EHR/EMR is set-up to report this year’s COVID-19 products.

These are the vaccines available this year: 

*Pfizer 6 mos – 4 years is no longer available.
**This is a protein, non-mRNA based vaccine.

When placing COVID-19 orders, please remember to: 

  1. Complete a current COVID-19 reconciliation.
  2. Submit your temperature data. Upload the CSV file into PhilaVax. Email the LTD file to tempcheck@phila.gov. 

All 2024-2025 COVID-19 products are no longer approved for use.

  • Remove all 2024-2025 COVID-19 vaccines from storage units immediately, even if they are not expired.
  • Discard any open vials of vaccine. Use this guide to adjust doses out of your inventory. 
  • Return any unopened vials or syringes using the Vaccine Return Guide.
  • Mark the reason as “Other” and, in the comment box, type in “Deauthorized.”

Updated ACIP Recommendations

On September 18-19, 2025, CDC’s Advisory Committee on Immunization Practices (ACIP) voted to recommend:

  • Any person 6 months and up can receive the COVID-19 vaccine after discussing it with their healthcare provider under a “shared clinical decision-making” model.

Clinical Recommendations

Immunization decisions should continue to be made using shared decision-making between clinicians, patients, and their families.

  • Persons with certain underlying medical conditions should receive the COVID-19 vaccine.
    • Patients who do not meet high-risk criteria may choose to receive the COVID-19 vaccine after speaking to their healthcare provider.
  • Infants under 6 months of age experience the highest COVID-19 hospitalization rates. There is no approved COVID-19 vaccine for infants under 6 months of age, making maternal vaccination the only way to protect this age group.

Questions?

For product availability questions: dphproviderhelp@phila.gov

For all other inquiries: vaccines@phila.gov

Thank you for your continued commitment to protecting Philadelphians against vaccine-preventable diseases!